COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Covidien (NYSE:COV), a leading global provider of healthcare products, today announced the results of the PUFS (Pipeline for Uncoilable or Failed AneurysmS) clinical study at the Society of NeuroInterventional Surgery 8th Annual Meeting here.
